Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
OWLWHO's Profile
No results found.

Recent Articles

  • KBR and ACMI Properties Unite for Spaceflight Food Innovation
  • Heritage Commerce Corp's Board Leadership Transition Unveiled
  • Maxus Mining Expands Options and Continues Growth in Exploration
  • Exciting New Drill Results at Mount Polley by Imperial Metals
  • Ibotta Inc. Securities Lawsuit Offers Chance for Investors
  • Iovance Biotherapeutics Faces Class Action Lawsuit from Investors
  • Pivot Bio's Strategic Relocation to Transform AgTech Landscape
  • Bantam Pharmaceutical's Innovation at ASCO 2025: BTM-3566
  • Understanding Distribution Sources of Cohen & Steers Fund
  • Silver Star Properties Navigates Legal Challenges and Strategy Update
  • Celebrating Excellence in the Building Industry: Awards 2025
  • BOXABL Embraces Bitcoin Strategy for Treasury Reserves
  • Johnson & Johnson's IMAAVY Hits Myasthenia Gravis Market
  • Cohen & Steers Total Return Realty Fund Updates for Investors
  • SFC Enhances Community Engagement with New Ice Rink Management
  • Boehringer Ingelheim Unveils Promising Cancer Trials at ASCO 2025
  • Soleno Therapeutics Advances in Treating Hyperphagia for PWS
  • Embracing Peace Through Collective Prayer and Support
  • Understanding Distribution Sources for Cohen & Steers' Fund
  • Innovative Cancer Research from RWJBarnabas Health Surfaces
  • Abeona's ZEVASKYN Breakthrough: A New Hope for DEB Patients
  • Silvercorp Exhibits Strong Fiscal Year-End Performance 2025
  • Univest Securities Completes $5 Million Offering for WORK Medical Tech
  • Kura Oncology and Kyowa Kirin Unveil Ziftomenib Trial Findings
  • Merus Showcases Promising Efficacy of Petosemtamab with Pembrolizumab
  • Iovance Biotherapeutics Reveals 5-Year Study on Amtagvi® Efficacy
  • Daktronics Engages at Leading Investor Conference This May
  • Allogene Therapeutics Shares Key ASCO 2025 Abstracts on CAR T Developments
  • IMUNON Seeks to Withdraw Registration Amid Growth Plans
  • Abcourt Mines Inc. Reports Solid Third Quarter Progress
  • PDS Biotech Shares Positive Results for Versamune® HPV Treatments
  • Servotronics' Proxy Contest Conclusion and Upcoming Meeting
  • Haivision to Unveil Financial Insights for Q2 Fiscal 2025
  • M-tron Industries, Inc. Announces Upcoming Investor Meeting
  • Rigel Pharmaceuticals Set for Major Presentations at ASCO 2025
  • Investors Can Join Digimarc Corporation Class Action Today
  • ImCheck Therapeutics Showcases Promising AML Therapy Results
  • Legend Biotech Reveals Significant Updates in Cancer Treatment
  • ROHM Introduces Next-Gen Compact NIR LEDs for Advanced Applications
  • Cullinan Therapeutics and Partners Showcase Breakthrough Cancer Trial Findings
  • Biodesix Unveils Promising Data on VeriStrat Test for NSCLC
  • Acceleware Ltd. Achieves Significant Progress in Q1 2025
  • Genmab Unveils Late-Stage Data Ahead of ASCO 2025 Meeting
  • Petrus Resources Shares Success of Annual Meeting Outcomes
  • Exciting Phase 2 Results from Actuate's Elraglusib in Cancer Treatment
  • Candel Therapeutics Advances Localized Prostate Cancer Treatment
  • Adagene Showcases Promising Results for ADG126 in Cancer Trials
  • Banco Comercial Português Highlights Key AGM Resolutions
  • Wheaton Precious Metals Unveils 2024 Reports on Sustainability and Climate
  • Novita Reports Encouraging Phase 2 Trial Results for NP-G2-044
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site